In conclusion, the bla CTX-M-1 IncI1/ST3 plasmid, which is dominant in various animal species in Europe and has also been reported in humans infected with S. enterica, appears to be dominant in foodand non-food-producing Tunisian animals. These data underline the international role of the bla CTX-M-1 IncI1/ST3 plasmid in ESBL epidemiology in animals. The risk of dissemination of the bla CTX-M-1 IncI1/ST3 plasmid from E. coli to S. enterica in Tunisia, as reported in Europe, is also a major concern. Furthermore, this study suggests that the surprisingly high prevalence of CTX-M-1 producers in the Tunisian community might result from the abundance of the bla CTX-M-1 IncI1/ST3 plasmid in animals. There is an urgent need to set up surveillance systems for antimicrobial resistance and antibiotic usage in animals (particularly in the food chain) in Tunisia.
1,2 Since its first description in France in 1996, the epidemiologically successful enzyme VIM-2 has been traced in resistant P. aeruginosa strains from various European countries (e.g. Spain, Italy, Croatia, Greece, the Netherlands and Turkey) and more recently in strains from northern (Tunisia and Algeria) and southern (South Africa) Africa. 1,3 -6 One study also mentioned its occurrence in Kenya. 7 Illustrating the spread of the VIM-2-encoding gene, bla VIM-2 , in sub-Saharan Africa countries, we found here that P. aeruginosa strains from the Ivory Coast harboured an atypical class I integron previously described in sporadic isolates from other continents.
Twelve P. aeruginosa isolates that were non-susceptible to imipenem according to the EUCAST interpretation rules (imipenem MIC .4 mg/L) were recovered from separate patients hospitalized in the intensive care unit of the teaching hospital in Abidjan, Ivory Coast, between February 2009 and November 2011. A double-disc (10 mg of imipenem, 2.5 mmol of EDTA) synergy test and an MBL Etest (imipenem+EDTA; bioMérieux, Craponne, France) were performed and found to be positive with seven of these isolates, suggesting the production of an Ambler class B b-lactamase (MIC of imipenem ≥256 mg/L; MIC of imipenem + EDTA 32 mg/L). PCR and DNA sequencing experiments revealed the presence of the gene bla VIM-2 in these isolates. All were highly resistant to carbapenems (imipenem MIC ≥128 mg/L, meropenem MIC ≥32 mg/L and doripenem MIC ≥32 mg/L), ceftazidime (MIC ≥64 mg/L), aminoglycosides (tobramycin MIC ≥128 mg/L) and ciprofloxacin (MIC ≥16 mg/L), but remained susceptible to aztreonam (MIC ≤1 mg/L) and colistin (MIC ≤4 mg/L). Six isolates were responsible for bloodstream (n¼ 3), urinary tract (n¼ 2) and pulmonary (n¼ 1) infections; the last one was considered to be a catheter contaminant. Their genetic relatedness was investigated by multiple-locus variablenumber tandem-repeat analysis using eight variable-number tandem repeats, as described previously. 8 All the VIM-2-positive isolates turned out to belong to the same epidemic clone (serotype O6), which was assigned to a new sequence type (ST), ST1488, after multilocus sequence typing (MLST) analysis. Interestingly, the closest ST found in the PubMLST database (http://pubmlst.org/paeruginosa), ST233, relates to a P. aeruginosa strain (serotype O6) identified in Sweden in 2006 from a patient repatriated from Ghana. Nucleotide sequence alignments demonstrated that this strain isolated from Ghana carried the same bla VIM-2 -containing integron, In559, as ST1488 (Figure 1) . 9 Since Ghana and the Ivory Coast are neighbouring countries, this suggests that closely related multidrug-resistant genotypes are present in this region of the African continent.
Screening for additional b-lactamase genes by PCR (bla TEM , bla SHV, bla PER , bla GES , bla VEB , bla IMP , bla NDM , bla SPM , bla PSE and bla OXA including bla ) revealed that the seven isolates except one (12.871) harboured bla OXA-4 , which codes for the narrow-spectrum oxacillinase OXA-4. The gene was located on a class 1 integron upstream of the aadA2 and cmlA1 cassettes, which code for the aminoglycoside-modifying enzyme ANT(3 ′′ ) (streptomycin and spectinomycin resistance) and for an active efflux pump accommodating chloramphenicol, respectively. PCR experiments using primers specific to 5 failed to detect a class 1 integron associated with bla VIM-2 in the strains. To characterize the genetic environment of bla VIM-2 , a BamHI library of strain 12.871 DNA was cloned into the BamHIrestricted plasmid pK18 (Km R ). Transformants of E. coli DH5a were selected on Mueller-Hinton agar plates containing 100 mg/L ampicillin and 30 mg/L kanamycin. Compared with strain DH5a, carrying the empty pK18 vector, all the recombinant clones tested displayed high levels of resistance to b-lactams except aztreonam. Sequence analysis of the 6224 kb insert from one of these clones led to the identification of a class 1 integron with a 5
′ CS sequence and gene tniC at its 3 ′ end. This genetic structure was found to carry the following gene cassettes downstream of the integrase gene intI1: aacA7 (encoding acetyltransferase AAC6
′ -Il, which confers amikacin resistance), bla VIM-2 , dhfrB5 (encoding a dihydrofolate reductase, providing trimethoprim resistance) and aacC5b (encoding an uncharacterized aminoglycoside acetyltransferase). Interestingly, this genetic structure was identical to that of bla VIM-2 -containing integrons characterized in P. aeruginosa from the USA (AY943084), Taiwan, Russia (AM749810), India (HQ005291) and the Indian Ocean (AM296017), but was different from integrons reported so far in African countries other than Ghana (Figure 1) . 10 Interestingly, upstream of the intI1 gene, we could identify the transposase gene tnpA from ISPa58 (ISfinder database, http://www-is.biotoul.fr). The sequence was 100% identical to that of tnpA belonging to the Tn3/ Tn21 family (JX194160). Repeated assays to visualize a plasmid by the Kieser method were unsuccessful. Southern experiments using a 750 bp bla VIM-2 probe labelled with digoxigenin-dUTP (DIG DNA Labelling and Detection Kit, Roche Diagnostics, Meylan, France) and I-CeuI-cleaved total DNA from strain 12.871 yielded a positive band after hybridization, thus indicating that the bla VIM-2 gene is carried by the genome in this strain.
Little information is still available regarding the spread of bla MBL genes in African countries. Our study confirms the presence in Africa of specific VIM-2-carrying integrons previously reported in other continents.
The nucleotide sequence reported in this paper was assigned GenBank accession number KC821786.
